{
    "Case ID": "082735",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "patent_validity": [
                "'426 patent",
                "'728 patent"
            ],
            "infringement_analysis": [
                "non-infringement",
                "obviousness",
                "uncertainty in dose equivalence calculations"
            ],
            "relevant_statute": [
                "Patented Medicines (Notice of Compliance) Regulations",
                "NOC Regulations"
            ],
            "evidence_presented": [
                "affidavits",
                "expert testimonies",
                "cross-examinations"
            ],
            "decision_reasoning": [
                "claim construction",
                "obviousness",
                "utility",
                "sufficiency"
            ],
            "result_of_case": [
                "prohibition granted for '426 patent",
                "prohibition denied for '728 patent"
            ],
            "cost_awards": [
                "half to Bayer"
            ],
            "cause_of_action": [
                "potential patent infringement"
            ],
            "procedure_followed": [
                "reviewing affidavits, expert testimonies, and cross-examinations"
            ],
            "application_details": [
                "Bayer sought to prohibit Cobalt from obtaining regulatory approval for its generic version of YAZ tablets"
            ]
        }
    ]
}